«1234567»Seite
8 articles with references, page 2 of 8

Original article

Atrial Fibrillation: Its Prevalence and Risk Factor Profile in the German General Population

Dtsch Arztebl Int 2012; 109(16): 293-9; DOI: 10.3238/arztebl.2012.0293

Schnabel, R B; Wilde, S; Wild, P S; Munzel, T; Blankenberg, S

1. Miyasaka Y, Barnes ME, Gersh BJ, et al.: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119–25. CrossRef MEDLINE
2. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO: Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 2011; 13: 1110–7. CrossRef MEDLINE
3. Lloyd-Jones DM, Wang TJ, Leip EP, et al.: Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110: 1042–6. CrossRef MEDLINE
4. Currie CJ, Jones M, Goodfellow J, et al.: Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin. Heart 2006; 92: 196–200. CrossRef MEDLINE PubMed Central
5. Wang TJ, Larson MG, Levy D, et al.: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003; 107: 2920–5. CrossRef MEDLINE
6. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946–52. MEDLINE
7. Nabauer M, Gerth A, Limbourg T, et al.: The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2009; 11: 423–34. CrossRef MEDLINE PubMed Central
8. Camm AJ, Kirchhof P, Lip GY, et al.: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369–429. CrossRef MEDLINE
9.Schnabel RB, Schulz A, Wild PS et al.: Non-invasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 2011; 4: 348–50. CrossRef MEDLINE
10. Schnabel RB, Sullivan LM, Levy D, et al.: Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739–45. CrossRef MEDLINE
11. Schnabel RB, Aspelund T, Li G, et al.: Validation of an atrial fibrillation risk algorithm in whites and african americans. Arch Intern Med 2010; 170: 1909–17. CrossRef MEDLINE PubMed Central
12. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864–70. CrossRef MEDLINE
13. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 2010; 137: 263–72. CrossRef MEDLINE
14. Lip GY, Frison L, Halperin JL, Lane DA: Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 2010; 41: 2731–8. CrossRef MEDLINE
15. Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857–67. MEDLINE
16.Holstenson E, Ringborg A, Lindgren P, et al.: Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. Europace 2011; 13: 23–30. CrossRef MEDLINE
17.Aliot E, Breithardt G, Brugada J, et al.: An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality. Europace 2010; 12: 626–33. CrossRef MEDLINE PubMed Central
18.Ford ES, Ajani UA, Croft JB, et al.: Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med 2007; 356: 2388–98. CrossRef MEDLINE
19. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840–4. CrossRef MEDLINE
20.Psaty BM, Manolio TA, Kuller LH, et al.: Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455–61. MEDLINE
21.Schnabel RB, Larson MG, Yamamoto JF, et al.: Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010; 121: 200–7. CrossRef MEDLINE PubMed Central
22.Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P: Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry. Clin Res Cardiol 2011; 100: 897–905. CrossRef MEDLINE PubMed Central
23.Nieuwlaat R, Olsson SB, Lip GY, et al.: Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J 2007; 153: 1006–12. CrossRef MEDLINE
24.Lip GY: Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice. Thromb Haemost 2010; 103: 683–5. CrossRef MEDLINE
25.Hindricks G, Piorkowski C, Tanner H, et al.: Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307–13. CrossRef MEDLINE
e1.Dormann H, Diesch K, Ganslandt T, Hahn EG, et al.: Kennzahlen und Qualitätsindikatoren einer medizinischen Notaufnahme. Dtsch Arztebl Int 2010; 107(15): 261–7. VOLLTEXT
e2.R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3–900051–08–9. www.R-project.org.
e3.Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864–70. CrossRef MEDLINE
e4.Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 2010; 137: 263–72. CrossRef MEDLINE
e5. Schnabel RB, Sullivan LM, Levy D, et al.: Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739–45. MEDLINE
e6.Trappe JH: Atrial Fibrillation: Established and innovative methods of evaluation and treatment. Dtsch Artzebl Int 2012; 109(1–2): 1–7. MEDLINE PubMed Central